Arthritis Drugs Archive | 2007

Arthritis Drugs

Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.


Arthritis Drugs - Issue: 35

Judge Finds Plaintiff's Claims Not 'Truly' Severed, Remands Case

Read Full Article

MDL Judge Rejects Plaintiffs' Pursuit of 2nd-Filed, State Vioxx Actions

Read Full Article

Plaintiffs Seek Appeal of Court's Protective Order for Martin Report

Read Full Article

N.J. Jury Awards $47.5 Million to Idaho Couple in Vioxx Trial

Read Full Article

Learned Intermediary Bars Humira Neurological Disorder Claim, Judge Says

Read Full Article

Merck to Appeal $7.75M Verdict After Judge's Inaction Let Award Stand

Read Full Article



Arthritis Drugs - Issue: 34

Vioxx MDL Court to Hear Oral Argument on Motions for New Trials

Read Full Article

FDA Advisory Panel to Review Safety of Merck's Cox-2 Arcoxia

Read Full Article




ISSUES BY YEAR




The HarrisMartin VerdicTrack



The HarrisMartin VerdicTrack lets you track verdicts by product, state, defendant, or expert.